Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
23.96
+0.30 (1.27%)
At close: May 8, 2026, 4:00 PM EDT
24.43
+0.47 (1.96%)
After-hours: May 8, 2026, 6:27 PM EDT
Alamar Biosciences Revenue
In the year 2025, Alamar Biosciences had annual revenue of $74.21M with 195.17% growth.
Revenue (ttm)
$74.21M
Revenue Growth
+195.17%
P/S Ratio
22.02
Revenue / Employee
$334,284
Employees
222
Market Cap
1.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.21M | 49.07M | 195.17% |
| Dec 31, 2024 | 25.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionALMR News
- 2 days ago - Alamar Biosciences reports Q1 EPS ($1.74) vs. (68c) last year - TheFly
- 2 days ago - Alamar Biosciences Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 5 days ago - Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference - GlobeNewsWire
- 10 days ago - Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026 - GlobeNewsWire
- 20 days ago - Alamar Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 20 days ago - Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ - PRNewsWire
- 22 days ago - Cathie Wood’s ARK Investment buys 537.5K shares of Alamar Biosciences today - TheFly
- 23 days ago - Alamar Biosciences valued at $1.5 billion as shares jump in Nasdaq debut - Reuters